智醫科學

AI醫療技術、應用與市場動態

【乳癌】基於術前血漿樣本,利用機器學習預測HR+/HER2-乳癌早期患者的術後預後

 【乳癌】基於術前血漿樣本,利用機器學習預測HR+/HER2-乳癌早期患者的術後預後


 文章出處  

Clinical Nutrition ESPEN 

 

 原文標題  

Plasma metabolomics combined with machine learning for postoperative prognostic stratification in hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer 

 

 文章序號  

12100 

 

智醫科學-AI醫療技術、應用與市場動

Copyright ©2026 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.